Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2015

01-10-2015 | Stanford Multidisciplinary Seminars

Primary Gastric Hodgkin’s Lymphoma: An Extremely Rare Entity and A Diagnostic Challenge

Authors: Saurabh Sethi, John Patrick Higgins, Daniel A. Arber, Brendan Visser, Subhas Banerjee

Published in: Digestive Diseases and Sciences | Issue 10/2015

Login to get access

Excerpt

A 71-year-old man was admitted to Stanford University Hospital with a 1-year history of poor appetite, 20 lbs weight loss, and recent episodes of hematemesis. He did not complain of abdominal pain, dysphagia, odynophagia, fever, or chills. His past medical history was significant for hypertension and gastro-esophageal reflux disease. The family and social history were unremarkable. Physical examination revealed a thin male with normal vital signs. There was no peripheral lymphadenopathy, and examination of the abdomen was unremarkable, with no enlargement of the liver or spleen or ascites. Laboratory investigations revealed iron deficiency anemia with a hemoglobin of 7.5 g/dL, WBC of 7,100/µL, and platelet count of 365,000/µL. His serum electrolytes and liver function tests were normal. Blood transfusion was declined due to religious beliefs. …
Literature
1.
go back to reference Devaney K, Jaffe ES. The surgical pathology of gastrointestinal Hodgkin’s disease. Am J Clin Pathol. 1991;95:794–801.PubMed Devaney K, Jaffe ES. The surgical pathology of gastrointestinal Hodgkin’s disease. Am J Clin Pathol. 1991;95:794–801.PubMed
2.
go back to reference Soderstrom KO, Joensusn H. Primary Hodgkin’s disease of the stomach. Am J Clin Pathol. 1988;89:806–809.PubMed Soderstrom KO, Joensusn H. Primary Hodgkin’s disease of the stomach. Am J Clin Pathol. 1988;89:806–809.PubMed
3.
go back to reference Brooks JJ, Enterline HT. Primary gastric lymphomas: a clinicopathological study of 58 cases with long term follow-up and literature review. Cancer. 1983;51:701–711.CrossRefPubMed Brooks JJ, Enterline HT. Primary gastric lymphomas: a clinicopathological study of 58 cases with long term follow-up and literature review. Cancer. 1983;51:701–711.CrossRefPubMed
4.
go back to reference Nakanuma Y, Kuruyama H, Kurushima K. An autopsy case of malignant histiocytosis with reed-sternberg like cells. Acta Pathol Jpn. 1989;39:79–83.PubMed Nakanuma Y, Kuruyama H, Kurushima K. An autopsy case of malignant histiocytosis with reed-sternberg like cells. Acta Pathol Jpn. 1989;39:79–83.PubMed
5.
go back to reference Satti MB, Al Idrissi HY, Ismail MH, Ginden YM, Al-Quorain AA. Anaplastic Ki-1 (CD30) positive large cell lymphoma of the stomach mimicking Hodgkin’s disease. A case report and review of the literature. Ann Saudi Med. 1999;19:352–356.PubMed Satti MB, Al Idrissi HY, Ismail MH, Ginden YM, Al-Quorain AA. Anaplastic Ki-1 (CD30) positive large cell lymphoma of the stomach mimicking Hodgkin’s disease. A case report and review of the literature. Ann Saudi Med. 1999;19:352–356.PubMed
6.
go back to reference Barry TS, Jaffe ES, Sorbora L, Raffeld M, Pittaluga S. Peripheral T-cell lymphomas expressing CD30 and CD15. Am J Surg Pathol. 2003;27:1513–1522.CrossRefPubMed Barry TS, Jaffe ES, Sorbora L, Raffeld M, Pittaluga S. Peripheral T-cell lymphomas expressing CD30 and CD15. Am J Surg Pathol. 2003;27:1513–1522.CrossRefPubMed
7.
go back to reference Mori N, Yatabe Y, Narita M, et al. Primary gastric Hodgkin’s disease. Morphologic, immunohistochemical and immunogenetic analyses. Arch Pathol Lab Med. 1995;119:163–166.PubMed Mori N, Yatabe Y, Narita M, et al. Primary gastric Hodgkin’s disease. Morphologic, immunohistochemical and immunogenetic analyses. Arch Pathol Lab Med. 1995;119:163–166.PubMed
8.
go back to reference Saito M, Tanaka S, Mori A, Toyoshima N, Irie T, Morioka M. Primary Gastric Hodgkin’s Lymphoma expressing a B-cell profile including Oct-2 and Bob-1 proteins. Int J Hematol. 2007;85:421–425.CrossRefPubMed Saito M, Tanaka S, Mori A, Toyoshima N, Irie T, Morioka M. Primary Gastric Hodgkin’s Lymphoma expressing a B-cell profile including Oct-2 and Bob-1 proteins. Int J Hematol. 2007;85:421–425.CrossRefPubMed
9.
go back to reference Ogawa Y, Chung YS, Nakata B, et al. A case of primary Hodgkin’s disease of the stomach. J Gastroenterol. 1995;30:103–107.CrossRefPubMed Ogawa Y, Chung YS, Nakata B, et al. A case of primary Hodgkin’s disease of the stomach. J Gastroenterol. 1995;30:103–107.CrossRefPubMed
10.
go back to reference Hossain FS, Koak Y, Khan FH. Primary gastric Hodgkin’s lymphoma. World J Surg Oncol. 2007;21:119.CrossRef Hossain FS, Koak Y, Khan FH. Primary gastric Hodgkin’s lymphoma. World J Surg Oncol. 2007;21:119.CrossRef
11.
go back to reference Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin’s disease: epidemiologic characteristics in international data. Int J Cancer. 1997;70:375–382.CrossRefPubMed Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin’s disease: epidemiologic characteristics in international data. Int J Cancer. 1997;70:375–382.CrossRefPubMed
12.
go back to reference Jarrett AF, Armstrong AA, Alexander E. Epidemiology of EBV and Hodgkin’s lymphoma. Ann Oncol. 1996;7:5–10.CrossRefPubMed Jarrett AF, Armstrong AA, Alexander E. Epidemiology of EBV and Hodgkin’s lymphoma. Ann Oncol. 1996;7:5–10.CrossRefPubMed
Metadata
Title
Primary Gastric Hodgkin’s Lymphoma: An Extremely Rare Entity and A Diagnostic Challenge
Authors
Saurabh Sethi
John Patrick Higgins
Daniel A. Arber
Brendan Visser
Subhas Banerjee
Publication date
01-10-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3616-x

Other articles of this Issue 10/2015

Digestive Diseases and Sciences 10/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine